• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Israel
  • Rise of obesity
  • Radiopharmaceuticals
  • Biosimilars
  • Aging
  • IVDs on the rise
  • Coronavirus
  • Artificial intelligence

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

March 4, 2004

View Archived Issues

Complementary effects of rosiglitazone and metformin in type 2 diabetes

Read More

Johnson & Johnson to acquire Merck's stake in European nonRx joint venture

Read More

New round of financing at Igeneon to advance lead candidates

Read More

Nautilus develops enhanced IFNbeta molecules for multiple sclerosis

Read More

New data support benefit of Namenda for Alzheimer's

Read More

Results from two HspE7 trials

Read More

Positive phase I/II results for NicVAX

Read More

Regeneron to test IL-1 Trap in phase IIb study

Read More

NOP World Heath report on Symbyax

Read More

Cell Therapeutics strengthens late-stage development product pipeline

Read More

Antisoma continues to acquire new products and advance existing programs

Read More

Solifenacin reported both safe and effective in overactive bladder

Read More

MDM2 directly suppresses p21: broader anticancer activity for antisense MDM2 inhibitors

Read More

Orchid scientists develop new COX inhibitors

Read More

Novel 5-HT2A receptor antagonists and their use covered by Biovitrum patent

Read More

Janssen researchers present NADPH oxidase inhibitors for arthritis and AD

Read More

Aventis describes three novel series of NHE-1 inhibitors

Read More

New protein kinase inhibitors for cancer and other disorders discovered at Janssen

Read More

New 5-HT6 receptor ligands prepared and tested at Wyeth

Read More

Targacept claims new nAChR modulators with utility in pain and CNS disorders

Read More

New PDE4 inhibitors with utility in cognition disorders identified at Memory Pharmaceuticals

Read More

Lilly to advance LY-519818 into registrational studies

Read More

Endpoint met in phase IIa study of DMI-7958

Read More

Compugen discovers novel soluble CD40 protein

Read More

Myfortic receives FDA approval

Read More

ARH-460-16-2 set to enter clinic early next year

Read More

Abbott and Millennium identify melanocortin receptor antagonist for disease-associated weight loss

Read More

H3 Pharma submits Sanvar IR NDA

Read More

Novel CDK inhibitor with in vitro antiapoptotic activity described

Read More

Strathclyde Institute for Drug Research seeks support for development of restenosis treatment

Read More

Novel anticonvulsant, YM-928, effective in generalized seizure models

Read More

Protective effects of brain-derived neurotrophic factor enhanced with RS-0466

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 6, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for June 6, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 3, 2025
  • Cancer cell in the cross-hairs

    Pan-cancer proteome atlas reveals new biomarkers and targets

    BioWorld Science
    An international group of scientists has completed the first draft of The Pan-Cancer Proteome Atlas (TPCPA). The project is based on mass spectrometry of 22...
  • Biotech deal illustration

    City hits the town with $1B-plus deal with Biogen

    BioWorld
    A development deal with Biogen Inc. could eventually bring City Therapeutics Inc. about $1 billion in milestone payments. It’s a step in the direction the company...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe